Jenburkt Pharmaceuticals Ltd
BSE:524731
Income Statement
Earnings Waterfall
Jenburkt Pharmaceuticals Ltd
Revenue
|
1.4B
INR
|
Cost of Revenue
|
-313.2m
INR
|
Gross Profit
|
1.1B
INR
|
Operating Expenses
|
-785.6m
INR
|
Operating Income
|
284.5m
INR
|
Other Expenses
|
-40m
INR
|
Net Income
|
244.5m
INR
|
Income Statement
Jenburkt Pharmaceuticals Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
736
N/A
|
762
+4%
|
784
+3%
|
809
+3%
|
828
+2%
|
852
+3%
|
882
+4%
|
911
+3%
|
940
+3%
|
936
0%
|
937
+0%
|
972
+4%
|
979
+1%
|
1 033
+6%
|
980
-5%
|
1 061
+8%
|
1 120
+6%
|
1 147
+2%
|
1 209
+5%
|
1 162
-4%
|
1 176
+1%
|
1 226
+4%
|
1 202
-2%
|
1 224
+2%
|
1 237
+1%
|
1 189
-4%
|
1 155
-3%
|
1 118
-3%
|
1 100
-2%
|
1 093
-1%
|
1 190
+9%
|
1 241
+4%
|
1 252
+1%
|
1 240
-1%
|
1 279
+3%
|
1 283
+0%
|
1 298
+1%
|
1 367
+5%
|
1 348
-1%
|
1 372
+2%
|
1 383
+1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(239)
|
(274)
|
(258)
|
(259)
|
(264)
|
(259)
|
(269)
|
(277)
|
(283)
|
(277)
|
(282)
|
(293)
|
(294)
|
(306)
|
(297)
|
(307)
|
(315)
|
(340)
|
(364)
|
(364)
|
(382)
|
(376)
|
(359)
|
(356)
|
(352)
|
(342)
|
(306)
|
(301)
|
(300)
|
(309)
|
(329)
|
(327)
|
(316)
|
(327)
|
(315)
|
(312)
|
(312)
|
(346)
|
(314)
|
(320)
|
(313)
|
|
Gross Profit |
497
N/A
|
489
-2%
|
526
+8%
|
550
+5%
|
564
+2%
|
593
+5%
|
614
+3%
|
634
+3%
|
657
+4%
|
659
+0%
|
654
-1%
|
679
+4%
|
685
+1%
|
727
+6%
|
683
-6%
|
753
+10%
|
806
+7%
|
807
+0%
|
846
+5%
|
798
-6%
|
794
0%
|
850
+7%
|
843
-1%
|
868
+3%
|
885
+2%
|
847
-4%
|
849
+0%
|
817
-4%
|
800
-2%
|
784
-2%
|
861
+10%
|
913
+6%
|
936
+3%
|
913
-2%
|
964
+6%
|
971
+1%
|
986
+2%
|
1 022
+4%
|
1 034
+1%
|
1 053
+2%
|
1 070
+2%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(399)
|
(389)
|
(424)
|
(438)
|
(444)
|
(467)
|
(474)
|
(487)
|
(501)
|
(514)
|
(518)
|
(526)
|
(536)
|
(548)
|
(566)
|
(581)
|
(612)
|
(584)
|
(561)
|
(565)
|
(562)
|
(614)
|
(642)
|
(665)
|
(682)
|
(673)
|
(662)
|
(632)
|
(610)
|
(605)
|
(635)
|
(656)
|
(679)
|
(659)
|
(693)
|
(717)
|
(733)
|
(741)
|
(756)
|
(770)
|
(786)
|
|
Selling, General & Administrative |
(161)
|
(367)
|
(175)
|
(180)
|
(186)
|
(190)
|
(196)
|
(202)
|
(206)
|
(215)
|
(222)
|
(227)
|
(238)
|
(252)
|
(255)
|
(270)
|
(273)
|
(277)
|
(290)
|
(293)
|
(304)
|
(592)
|
(322)
|
(341)
|
(352)
|
(640)
|
(358)
|
(346)
|
(340)
|
(575)
|
(329)
|
(341)
|
(353)
|
(630)
|
(370)
|
(380)
|
(388)
|
(706)
|
(393)
|
(401)
|
(412)
|
|
Research & Development |
0
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
|
Depreciation & Amortization |
(19)
|
(16)
|
(16)
|
(17)
|
(20)
|
(27)
|
(24)
|
(24)
|
(22)
|
(20)
|
(20)
|
(20)
|
(19)
|
(18)
|
(17)
|
(16)
|
(16)
|
(15)
|
(15)
|
(14)
|
(14)
|
(14)
|
(16)
|
(18)
|
(21)
|
(23)
|
(23)
|
(22)
|
(21)
|
(20)
|
(20)
|
(19)
|
(19)
|
(19)
|
(20)
|
(21)
|
(22)
|
(23)
|
(22)
|
(23)
|
(23)
|
|
Other Operating Expenses |
(220)
|
0
|
(233)
|
(241)
|
(238)
|
(250)
|
(254)
|
(262)
|
(273)
|
(280)
|
(277)
|
(280)
|
(279)
|
(278)
|
(294)
|
(295)
|
(323)
|
(292)
|
(256)
|
(259)
|
(244)
|
0
|
(304)
|
(306)
|
(309)
|
0
|
(281)
|
(264)
|
(250)
|
(0)
|
(286)
|
(295)
|
(307)
|
(0)
|
(303)
|
(316)
|
(323)
|
0
|
(340)
|
(346)
|
(350)
|
|
Operating Income |
98
N/A
|
100
+2%
|
102
+3%
|
113
+10%
|
120
+7%
|
126
+5%
|
140
+11%
|
147
+5%
|
156
+6%
|
145
-7%
|
136
-6%
|
153
+12%
|
149
-3%
|
179
+21%
|
117
-35%
|
172
+47%
|
194
+13%
|
223
+15%
|
285
+28%
|
232
-18%
|
232
0%
|
236
+2%
|
202
-15%
|
203
+1%
|
203
0%
|
174
-14%
|
187
+7%
|
185
-1%
|
190
+3%
|
178
-6%
|
226
+27%
|
257
+14%
|
257
0%
|
254
-1%
|
272
+7%
|
254
-6%
|
253
0%
|
281
+11%
|
278
-1%
|
283
+2%
|
284
+1%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(17)
|
4
|
(9)
|
(7)
|
(2)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
31
|
(4)
|
(5)
|
(5)
|
36
|
(6)
|
(5)
|
(5)
|
39
|
(5)
|
(5)
|
(4)
|
43
|
(4)
|
(4)
|
(4)
|
45
|
(4)
|
(3)
|
(3)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
15
|
(0)
|
17
|
15
|
12
|
20
|
26
|
30
|
34
|
27
|
29
|
29
|
29
|
28
|
33
|
37
|
37
|
33
|
32
|
32
|
31
|
(0)
|
37
|
37
|
39
|
1
|
40
|
41
|
43
|
(0)
|
45
|
47
|
49
|
0
|
49
|
50
|
51
|
2
|
50
|
49
|
47
|
|
Pre-Tax Income |
96
N/A
|
103
+7%
|
110
+7%
|
121
+10%
|
130
+7%
|
143
+10%
|
162
+13%
|
173
+7%
|
187
+8%
|
168
-10%
|
161
-4%
|
178
+10%
|
174
-3%
|
205
+18%
|
146
-29%
|
205
+40%
|
227
+11%
|
253
+11%
|
313
+24%
|
260
-17%
|
259
0%
|
266
+3%
|
235
-12%
|
235
0%
|
236
+0%
|
211
-11%
|
221
+5%
|
221
+0%
|
229
+3%
|
216
-5%
|
267
+23%
|
300
+12%
|
302
+1%
|
299
-1%
|
316
+6%
|
300
-5%
|
301
+0%
|
329
+9%
|
325
-1%
|
328
+1%
|
329
+0%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(27)
|
(28)
|
(30)
|
(31)
|
(29)
|
(47)
|
(52)
|
(61)
|
(70)
|
(60)
|
(60)
|
(60)
|
(61)
|
(70)
|
(59)
|
(69)
|
(75)
|
(81)
|
(85)
|
(74)
|
(74)
|
(68)
|
(64)
|
(66)
|
(65)
|
(63)
|
(63)
|
(62)
|
(57)
|
(51)
|
(65)
|
(76)
|
(75)
|
(76)
|
(80)
|
(75)
|
(84)
|
(83)
|
(85)
|
(83)
|
(84)
|
|
Income from Continuing Operations |
69
|
75
|
81
|
90
|
101
|
96
|
111
|
112
|
117
|
108
|
102
|
118
|
113
|
135
|
87
|
136
|
152
|
172
|
228
|
186
|
185
|
198
|
172
|
170
|
171
|
149
|
158
|
159
|
172
|
165
|
201
|
224
|
227
|
223
|
236
|
225
|
217
|
246
|
240
|
245
|
244
|
|
Net Income (Common) |
69
N/A
|
75
+9%
|
81
+7%
|
90
+12%
|
101
+12%
|
96
-4%
|
111
+15%
|
112
+2%
|
117
+4%
|
108
-8%
|
102
-6%
|
118
+16%
|
113
-5%
|
135
+20%
|
87
-36%
|
136
+57%
|
152
+12%
|
172
+13%
|
228
+32%
|
186
-19%
|
185
0%
|
198
+7%
|
172
-13%
|
170
-1%
|
171
+1%
|
149
-13%
|
158
+6%
|
159
+1%
|
172
+8%
|
165
-4%
|
201
+22%
|
224
+11%
|
227
+1%
|
223
-2%
|
236
+6%
|
225
-5%
|
217
-4%
|
246
+13%
|
240
-2%
|
245
+2%
|
244
0%
|
|
EPS (Diluted) |
14.93
N/A
|
16.32
+9%
|
16.44
+1%
|
18.36
+12%
|
21.89
+19%
|
20.75
-5%
|
24.04
+16%
|
24.43
+2%
|
25.47
+4%
|
23.18
-9%
|
22.1
-5%
|
25.65
+16%
|
25
-3%
|
29.05
+16%
|
18.86
-35%
|
29.54
+57%
|
33
+12%
|
37.5
+14%
|
49.54
+32%
|
40.34
-19%
|
40.27
0%
|
43.14
+7%
|
37.39
-13%
|
36.97
-1%
|
37.36
+1%
|
32.4
-13%
|
34.51
+7%
|
34.73
+1%
|
37.58
+8%
|
35.96
-4%
|
43.9
+22%
|
48.91
+11%
|
49.52
+1%
|
48.58
-2%
|
51.42
+6%
|
49.01
-5%
|
47.28
-4%
|
55.76
+18%
|
54.45
-2%
|
55.46
+2%
|
55.41
0%
|